Impact of the Global Budget Payment System on Expenditure of Cardiovascular Diseases: An Interrupted Time Series Analysis in Shanghai, China

被引:4
|
作者
Dou, Guanshen [1 ]
Zhang, Yilin [2 ]
He, Yunzhen [1 ]
Huang, Qiaoyun [3 ]
Ye, Yingfeng [1 ]
Zhang, Xinyu [1 ]
Wang, Weibing [4 ]
Ying, Xiaohua [1 ]
机构
[1] Fudan Univ, NHC Key Lab Hlth Technol Assessment, Dept Hlth Econ, Sch Publ Hlth, Shanghai 200032, Peoples R China
[2] London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England
[3] Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Yunnan, Peoples R China
[4] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200032, Peoples R China
关键词
global budget payment system; cardiovascular diseases; medical expenditure; China; HEALTH-CARE; INCENTIVES; INJECTIONS; PHYSICIANS; BEHAVIOR; PROGRAM; DRIVEN; PROFIT;
D O I
10.3390/ijerph16081385
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Since few studies evaluated the impact of the global budget payment system (GBPS) over time, and by expenditure type, this paper aims to evaluate the impact of the GBPS on expenditure of inpatients, and explores how hospitals curb the expenditure in patients with cardiovascular diseases (CVDs) in Shanghai. We built a time series model with the monthly expenditure of CVDs from 2009 to 2012. We evaluated the instant impact and trends impact of the GBPS and analyzed results based on medical expenditure types (e.g., drug, examination, cure, unclassified items), discharge number, and expenditure per capita. We found GBPS instantly dropped the medical expenditure by Chinese Yuan (CNY) 55.71 million (p < 0.001), and decreased the monthly increasing trend by CNY 4.23 million (p = 0.011). The discharge number had 10.4% instant reduction and 225.55 monthly decrease (p = 0.021) while the expenditure per capita experienced fewer changes. Moreover, the expenditure of drug and cure had an instant reduction of CNY 28.31 million and 16.28 million (p < 0.001). In conclusion, we considered the GBPS is an effective solution to control the expenditure of CVDs by decreasing the discharge number, and a focus on the drug and cure expenditures lead to greater spend reduction than other types of expenditures.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
    Guan, Xiaodong
    Tian, Ye
    Ross-Degnan, Dennis
    Man, Chunxia
    Shi, Luwen
    BMJ OPEN, 2018, 8 (07):
  • [22] Impact of pesticide regulations on mortality from suicide by pesticide in China: an interrupted time series analysis
    Yan, Yongfu
    Jiang, Yingying
    Liu, Rong
    Eddleston, Michael
    Tao, Chuanjiang
    Page, Andrew
    Wang, Lijun
    Feng, Guoshuang
    Liu, Shiwei
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [23] Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China
    Zhou, Qin
    Hu, Junxian
    Hu, Wensui
    Li, Hailin
    Lin, Guo-zhen
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [24] An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in Cyprus
    Panagiotis Petrou
    Applied Health Economics and Health Policy, 2015, 13 : 515 - 523
  • [25] INCENTIVE PAYMENT AND NONMANAGERIAL PRODUCTIVITY - AN INTERRUPTED TIME-SERIES ANALYSIS OF MAGNITUDE AND TREND
    WAGNER, JA
    RUBIN, PA
    CALLAHAN, TJ
    ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1988, 42 (01) : 47 - 74
  • [27] Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China
    Qin Zhou
    Junxian Hu
    Wensui Hu
    Hailin Li
    Guo-zhen Lin
    BMC Infectious Diseases, 23
  • [28] Effectiveness of hierarchical medical system policy: an interrupted time series analysis of a pilot scheme in China
    Hu, Huajie
    Wang, Ruilin
    Li, Huangqianyu
    Han, Sheng
    Shen, Peng
    Lin, Hongbo
    Guan, Xiaodong
    Shi, Luwen
    HEALTH POLICY AND PLANNING, 2023, 38 (05) : 609 - 619
  • [29] The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis
    Gianfranco Damiani
    Bruno Federico
    Angela Anselmi
    Caterina Bianca Neve Aurora Bianchi
    Giulia Silvestrini
    Lanfranco Iodice
    Pierluigi Navarra
    Roberto Da Cas
    Roberto Raschetti
    Walter Ricciardi
    BMC Health Services Research, 14
  • [30] The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis
    Damiani, Gianfranco
    Federico, Bruno
    Anselmi, Angela
    Bianchi, Caterina Bianca Neve Aurora
    Silvestrini, Giulia
    Iodice, Lanfranco
    Navarra, Pierluigi
    Da Cas, Roberto
    Raschetti, Roberto
    Ricciardi, Walter
    BMC HEALTH SERVICES RESEARCH, 2014, 14